Fundamental Analysis of INSPIRA TECHNOLOGIES OXY BHN(NASDAQ:IINN) stock

Fundamental Rating

Taking everything into account, IINN scores 1 out of 10 in our fundamental rating. IINN was compared to 187 industry peers in the Health Care Equipment & Supplies industry. IINN has a bad profitability rating. Also its financial health evaluation is rather negative. IINN does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IINN has reported negative net income.

IINN had a negative operating cash flow in the past year.

IINN had negative earnings in each of the past 5 years.

In the past 5 years IINN always reported negative operating cash flow.

1.2 Ratios

IINN has a worse Return On Assets (-121.14%) than 87.17% of its industry peers.

The Return On Equity of IINN (-196.55%) is worse than 75.94% of its industry peers.

		Industry Rank	Sector Rank
ROA	-121.14%
ROE	-196.55%
ROIC	N/A

ROA(3y)-83.64%

ROA(5y)-443.81%

ROE(3y)-120.05%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IINN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, IINN has more shares outstanding

IINN has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, IINN has a worse debt to assets ratio.

2.2 Solvency

IINN has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.

With a Debt to Equity ratio value of 0.10, IINN perfoms like the industry average, outperforming 58.82% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 2.61 indicates that IINN has no problem at all paying its short term obligations.

IINN has a Current ratio of 2.61. This is comparable to the rest of the industry: IINN outperforms 47.59% of its industry peers.

IINN has a Quick Ratio of 2.61. This indicates that IINN is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of IINN (2.61) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	2.61
Quick Ratio	2.61

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IINN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.84%, which is quite good.

EPS 1Y (TTM)11.84%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-400%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y23.47%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IINN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IINN. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IINN!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

INSPIRA TECHNOLOGIES OXY BHN

NASDAQ:IINN (12/23/2024, 6:25:36 PM)

After market: 1.18 +0.02 (+1.72%)

1.16

+0.27 (+30.32%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)03-25 2024-03-25/bmo

Earnings (Next)N/A N/A

Inst Owners1.06%

Inst Owner Change-28.45%

Ins Owners8.88%

Ins Owner ChangeN/A

Market Cap21.39M

Analysts82.86

Price Target13.26 (1043.1%)

Short Float %0.9%

Short Ratio1.11

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)35.32%

Min EPS beat(2)28.1%

Max EPS beat(2)42.53%

EPS beat(4)4

Avg EPS beat(4)27.91%

Min EPS beat(4)19.73%

Max EPS beat(4)42.53%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	3.73
P/tB	3.73
EV/EBITDA	N/A

EPS(TTM)-0.93

EYN/A

EPS(NY)-0.71

Fwd EYN/A

FCF(TTM)-0.54

FCFYN/A

OCF(TTM)-0.53

OCFYN/A

SpSN/A

BVpS0.31

TBVpS0.31

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-121.14%
ROE	-196.55%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-83.64%

ROA(5y)-443.81%

ROE(3y)-120.05%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset TurnoverN/A

Health

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	185.59%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.61
Quick Ratio	2.61
Altman-Z	N/A

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)114.64%

Cap/Depr(5y)78.28%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)11.84%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-400%

EPS Next Y23.47%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y17.89%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year7.9%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-29.71%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-32.2%

OCF growth 3YN/A

OCF growth 5YN/A

INSPIRA TECHNOLOGIES OXY BHN (IINN)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens